TheDose

Behentrimonium Methosulfate

Also known as BTMS, Docosyltrimethylammonium methyl sulfate, Behentrimonium methyl sulfate

CIRPubMed

Safe

CIR Expert Panel says: safe as used in cosmetics.”

Behentrimonium Methosulfate (BTMS, CAS 81646-13-1) is a quaternary ammonium cationic conditioner assessed by the CIR Expert Panel as part of the 2012 trimoniums group safety assessment (IJT 31(S3):296-341). The QRT records a Qualified Safe (SQ) finding: safe when formulated to be non-irritating. No product-type or rinse-off restriction was specified beyond the non-irritating formulation qualifier. Post-marketing adverse event data for behentrimonium chloride (the closely related chloride-salt analogue) reported only 0.69 undesirable effects per million units sold over five years, consistent with a low irritation potential for the class at typical use concentrations.


Primary cationic conditioning agent and emulsifier in hair conditioners, leave-on treatments, and hair masks; provides slip, detangling, and antistatic effects

CIR Expert Panel found safe for use in cosmetics when formulated to be non-irritating (SQ, IJT 31(S3):296-341, 2012)

Widely used in natural and clean-beauty formulations as a milder alternative to behentrimonium chloride due to the methosulfate counterion being considered less irritating in some formulations


Concerns
  • · As a cationic quaternary ammonium compound, potential for skin and eye irritation exists if formulated at elevated concentrations without appropriate non-irritating formulation controls
  • · The CIR group report covers trimoniums as a class; ingredient-specific clinical data for BTMS specifically are sparse in the published literature

CIR Expert Panel
Approved
safe when formulated to be non-irritating
[1]
CIR Expert Panel · Jul 1, 2018Live

CIR Quick Reference Table (12/2017, revised 07/2018) — Behentrimonium Methosulfate row: Finding=SQ, Citation=IJT 31(S3): 296-341 (2012)

Behentrimonium Methosulfate | SQ | safe when formulated to be non- irritating | IJT 31(S3): 296-341 (2012)QRT-122017revised072018.pdf, p. 11
Verificationpdf_textView source
[2]
Peer-reviewed (PubMed) · Dec 1, 2013

Confirmation of in vitro and clinical safety assessment of behentrimonium chloride-containing leave-on body lotions using post-marketing …

Verificationweb_textView on PubMed
Sources
2
PubMed citations
1
Evidence quality
limited
Last verified
Re-reviewed when a new CIR / SCCS opinion publishes.